Amneal Pharmaceuticals, Inc. (AMRX) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking Alpha • 03/10/26
TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600PRNewsWire • 01/27/26
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026GlobeNewsWire • 01/27/26
Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 01/22/26
Amneal Pharmaceuticals, Inc. (AMRX) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/14/26
KeifeRx Announces Research Collaboration and Option Agreement with Amneal Pharmaceuticals to Advance KFRX06, a Brain-Penetrant LRRK2 Program for Parkinson's DiseaseBusiness Wire • 01/09/26
Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®GlobeNewsWire • 12/22/25
Amneal: Growing Drug Portfolio, Positive Cash Flow, Outweighing Leverage RisksSeeking Alpha • 12/18/25
Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. HospitalsGlobeNewsWire • 12/09/25
Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson's DiseaseGlobeNewsWire • 12/05/25
Is Amneal Stock a Buy After Investment Firm Westshore Wealth Bought Over 1 Million Shares?The Motley Fool • 11/28/25
Amneal EVP Sells $1.6 Million in Shares as Stock Trades Near Multi-Year HighsThe Motley Fool • 11/21/25